Prof Rob Stein: key facts
- Kind of voice
- Academic
- Role
- Chief Investigator of the OPTIMA trial and Professor of Breast Oncology at the UCL Cancer Institute
- Quoted on
- Cancer
- Tracked press citations
- 3
- Most recently quoted
- 30 Sept 2026
“Our findings show that many patients can safely avoid chemotherapy without compromising their outcomes. These results mark an important and significant step toward more personalised treatment.”
What Prof Rob Stein has said
“OPTIMA addresses a long-standing challenge in breast cancer care: identifying who truly benefits from chemotherapy and who does not. Our findings show that many patients can safely avoid chemotherapy without compromising their outcomes.”
Chief Investigator of the OPTIMA trial and Professor of Breast Oncology at the UCL Cancer Institute · Cancer · 30 Sept 2026 · Gene test could spare thousands of breast cancer patients from unnecessary chemotherapy ↗
“Optima addresses a longstanding challenge in breast cancer care: identifying who truly benefits from chemotherapy and who does not. Our findings show that many patients can safely avoid chemotherapy without compromising their outcomes.”
professor of breast oncology at UCL · Cancer · 27 Aug 2026 · Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy ↗
Where Prof Rob Stein has been quoted
- Breast cancer patients could be spared chemotherapytelegraph.co.uk · 30 Sept 2026
- Gene test could spare thousands of breast cancer patients from unnecessary chemotherapywarwick.ac.uk · 30 Sept 2026
- Groundbreaking genomic test could spare millions of breast cancer patients chemotherapytheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.